Nevertheless, when viewed together, our results strongly suggest that sst5 expression in GHomas and ACTHomas, and sst5TMD4 expression in ACTHomas might represent useful molecular markers to predict the ultimate response of these pituitary adenoma types to BIM-23A760. This evidence concerns the gene SSTR5 and pituitary gland adenoma.